Literature DB >> 29761157

A Next-Generation Sequencing Primer-How Does It Work and What Can It Do?

Yuriy O Alekseyev1, Roghayeh Fazeli1, Shi Yang1, Raveen Basran1, Thomas Maher1, Nancy S Miller1, Daniel Remick1.   

Abstract

Next-generation sequencing refers to a high-throughput technology that determines the nucleic acid sequences and identifies variants in a sample. The technology has been introduced into clinical laboratory testing and produces test results for precision medicine. Since next-generation sequencing is relatively new, graduate students, medical students, pathology residents, and other physicians may benefit from a primer to provide a foundation about basic next-generation sequencing methods and applications, as well as specific examples where it has had diagnostic and prognostic utility. Next-generation sequencing technology grew out of advances in multiple fields to produce a sophisticated laboratory test with tremendous potential. Next-generation sequencing may be used in the clinical setting to look for specific genetic alterations in patients with cancer, diagnose inherited conditions such as cystic fibrosis, and detect and profile microbial organisms. This primer will review DNA sequencing technology, the commercialization of next-generation sequencing, and clinical uses of next-generation sequencing. Specific applications where next-generation sequencing has demonstrated utility in oncology are provided.

Entities:  

Keywords:  diagnostic test; microbiology; mutation; oncology; sequencing

Year:  2018        PMID: 29761157      PMCID: PMC5944141          DOI: 10.1177/2374289518766521

Source DB:  PubMed          Journal:  Acad Pathol        ISSN: 2374-2895


  135 in total

Review 1.  Next-generation sequencing for the diagnosis of hereditary pheochromocytoma and paraganglioma syndromes.

Authors:  Rodrigo A Toledo; Patricia L M Dahia
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-06       Impact factor: 3.243

Review 2.  High-throughput sequencing technologies.

Authors:  Jason A Reuter; Damek V Spacek; Michael P Snyder
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

3.  NCI-MATCH launch highlights new trial design in precision-medicine era.

Authors:  Caroline McNeil
Journal:  J Natl Cancer Inst       Date:  2015-07-03       Impact factor: 13.506

4.  Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.

Authors:  Laurent Castéra; Sophie Krieger; Antoine Rousselin; Angélina Legros; Jean-Jacques Baumann; Olivia Bruet; Baptiste Brault; Robin Fouillet; Nicolas Goardon; Olivier Letac; Stéphanie Baert-Desurmont; Julie Tinat; Odile Bera; Catherine Dugast; Pascaline Berthet; Florence Polycarpe; Valérie Layet; Agnes Hardouin; Thierry Frébourg; Dominique Vaur
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

5.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.

Authors:  Sarah S Kalia; Kathy Adelman; Sherri J Bale; Wendy K Chung; Christine Eng; James P Evans; Gail E Herman; Sophia B Hufnagel; Teri E Klein; Bruce R Korf; Kent D McKelvey; Kelly E Ormond; C Sue Richards; Christopher N Vlangos; Michael Watson; Christa L Martin; David T Miller
Journal:  Genet Med       Date:  2016-11-17       Impact factor: 8.822

6.  Targeted next generation sequencing for molecular diagnosis of Usher syndrome.

Authors:  María J Aparisi; Elena Aller; Carla Fuster-García; Gema García-García; Regina Rodrigo; Rafael P Vázquez-Manrique; Fiona Blanco-Kelly; Carmen Ayuso; Anne-Françoise Roux; Teresa Jaijo; José M Millán
Journal:  Orphanet J Rare Dis       Date:  2014-11-18       Impact factor: 4.123

7.  Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.

Authors:  Agus Darwanto; Anne-Mette Hein; Sascha Strauss; Yi Kong; Andrew Sheridan; Dan Richards; Eric Lader; Monika Ngowe; Timothy Pelletier; Danielle Adams; Austin Ricker; Nishit Patel; Andreas Kühne; Simon Hughes; Dan Shiffman; Dirk Zimmermann; Kai Te Kaat; Thomas Rothmann
Journal:  BMC Cancer       Date:  2017-05-22       Impact factor: 4.430

Review 8.  Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.

Authors:  Mary Alikian; Robert Peter Gale; Jane F Apperley; Letizia Foroni
Journal:  Biomol Detect Quantif       Date:  2017-02-14

9.  Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.

Authors:  Nicky D'Haene; Marie Le Mercier; Nancy De Nève; Oriane Blanchard; Mélanie Delaunoy; Hakim El Housni; Barbara Dessars; Pierre Heimann; Myriam Remmelink; Pieter Demetter; Sabine Tejpar; Isabelle Salmon
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

10.  Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.

Authors:  Chun Hang Au; Anna Wa; Dona N Ho; Tsun Leung Chan; Edmond S K Ma
Journal:  Diagn Pathol       Date:  2016-01-22       Impact factor: 2.644

View more
  16 in total

Review 1.  Emerging Role of Genomics and Cell-Free DNA in Breast Cancer.

Authors:  Lorenzo Gerratana; Andrew A Davis; Ami N Shah; Chenyu Lin; Carla Corvaja; Massimo Cristofanilli
Journal:  Curr Treat Options Oncol       Date:  2019-06-29

2.  Vismodegib as First-Line Treatment of Mutated Sonic Hedgehog Pathway in Adult Medulloblastoma.

Authors:  Waleed Kian; Laila C Roisman; Iris M Goldstein; Abed Abo-Quider; Benzion Samueli; Nadav Wallach; Farouq Alguayn; Walid Shalata; Dina Levitas; Olga Belochitski; Daniel Levin; Eyal Fenig; Konstantin Lavrenkov; Margarita Tokar; Nir Peled; Alexander Yakobson
Journal:  JCO Precis Oncol       Date:  2020-04-30

Review 3.  MRD in ALL: Optimization and Innovations.

Authors:  Eric Pierce; Benjamin Mautner; Joseph Mort; Anastassia Blewett; Amy Morris; Michael Keng; Firas El Chaer
Journal:  Curr Hematol Malig Rep       Date:  2022-05-26       Impact factor: 4.213

Review 4.  Next Generation Sequencing and Bioinformatics Analysis of Family Genetic Inheritance.

Authors:  Aquillah M Kanzi; James Emmanuel San; Benjamin Chimukangara; Eduan Wilkinson; Maryam Fish; Veron Ramsuran; Tulio de Oliveira
Journal:  Front Genet       Date:  2020-10-23       Impact factor: 4.599

Review 5.  Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children's Genomic Medicine Consortium.

Authors:  David Gregornik; Daria Salyakina; Marilyn Brown; Samuel Roiko; Kenneth Ramos
Journal:  Pharmacogenomics J       Date:  2020-08-26       Impact factor: 3.550

Review 6.  A primer on single-cell genomics in myeloid biology.

Authors:  Kyle Ferchen; Baobao Song; H Leighton Grimes
Journal:  Curr Opin Hematol       Date:  2021-01       Impact factor: 3.218

7.  A case of Vibrio vulnificus related wound infection diagnosed by next-generation sequencing.

Authors:  Linhui Li; Lingyan Wang; Chunhong Zhang; Peng Chen; Xu Luo
Journal:  IDCases       Date:  2019-01-24

Review 8.  Intraoral appliances for in situ oral biofilm growth: a systematic review.

Authors:  Nizam Abdullah; Farah Al-Marzooq; Suharni Mohamad; Normastura Abd Rahman; Hien Chi Ngo; Lakshman Perera Samaranayake
Journal:  J Oral Microbiol       Date:  2019-08-06       Impact factor: 5.474

9.  Expression and phylogeny of multidrug resistance protein 2 and 4 in African white backed vulture (Gyps africanus).

Authors:  Bono Nethathe; Aron Abera; Vinny Naidoo
Journal:  PeerJ       Date:  2020-12-01       Impact factor: 2.984

10.  Total Number of Alterations in Liquid Biopsies Is an Independent Predictor of Survival in Patients With Advanced Cancers.

Authors:  Peter Vu; Yulian Khagi; Paul Riviere; Aaron Goodman; Razelle Kurzrock
Journal:  JCO Precis Oncol       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.